BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21152869)

  • 1. 3,3'-diindolylmethane inhibits migration and invasion of human cancer cells through combined suppression of ERK and AKT pathways.
    Rajoria S; Suriano R; Wilson YL; Schantz SP; Moscatello A; Geliebter J; Tiwari RK
    Oncol Rep; 2011 Feb; 25(2):491-7. PubMed ID: 21152869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in ovarian cancer cells.
    Zou M; Zhang X; Xu C
    Cell Oncol (Dordr); 2016 Feb; 39(1):47-57. PubMed ID: 26510945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in thyroid cancer.
    Rajoria S; Suriano R; George A; Shanmugam A; Schantz SP; Geliebter J; Tiwari RK
    PLoS One; 2011 Jan; 6(1):e15879. PubMed ID: 21267453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3,3'-Diindolylmethane downregulates pro-survival pathway in hormone independent prostate cancer.
    Garikapaty VP; Ashok BT; Tadi K; Mittelman A; Tiwari RK
    Biochem Biophys Res Commun; 2006 Feb; 340(2):718-25. PubMed ID: 16380095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of G1 and G2/M cell cycle arrests by the dietary compound 3,3'-diindolylmethane in HT-29 human colon cancer cells.
    Choi HJ; Lim DY; Park JH
    BMC Gastroenterol; 2009 May; 9():39. PubMed ID: 19480695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxyfadichalcone C inhibits melanoma A375 cell proliferation and metastasis via suppressing PI3K/Akt and MAPK/ERK pathways.
    Peng X; Wang Z; Liu Y; Peng X; Liu Y; Zhu S; Zhang Z; Qiu Y; Jin M; Wang R; Zhang Q; Kong D
    Life Sci; 2018 Aug; 206():35-44. PubMed ID: 29782872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Phytochemical, DIM, Inhibits Proliferation, Migration, Invasion and TNF-α Induced Inflammatory Cytokine Production of Synovial Fibroblasts From Rheumatoid Arthritis Patients by Targeting MAPK and AKT/mTOR Signal Pathway.
    Du H; Zhang X; Zeng Y; Huang X; Chen H; Wang S; Wu J; Li Q; Zhu W; Li H; Liu T; Yu Q; Wu Y; Jie L
    Front Immunol; 2019; 10():1620. PubMed ID: 31396207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3,3'-Diindolylmethane inhibits angiogenesis and the growth of transplantable human breast carcinoma in athymic mice.
    Chang X; Tou JC; Hong C; Kim HA; Riby JE; Firestone GL; Bjeldanes LF
    Carcinogenesis; 2005 Apr; 26(4):771-8. PubMed ID: 15661811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of multi-targeted proliferation-linked signaling by 3,3'-diindolylmethane (DIM): from bench to clinic.
    Banerjee S; Kong D; Wang Z; Bao B; Hillman GG; Sarkar FH
    Mutat Res; 2011; 728(1-2):47-66. PubMed ID: 21703360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3'3-Diindolylmethane inhibits migration, invasion and metastasis of hepatocellular carcinoma by suppressing FAK signaling.
    Li WX; Chen LP; Sun MY; Li JT; Liu HZ; Zhu W
    Oncotarget; 2015 Sep; 6(27):23776-92. PubMed ID: 26068982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P21-activated kinase 1 stimulates colon cancer cell growth and migration/invasion via ERK- and AKT-dependent pathways.
    Huynh N; Liu KH; Baldwin GS; He H
    Biochim Biophys Acta; 2010 Sep; 1803(9):1106-13. PubMed ID: 20595063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3,3'-Diindolylmethane inhibits patient-derived xenograft colon tumor growth by targeting COX1/2 and ERK1/2.
    Tian X; Liu K; Zu X; Ma F; Li Z; Lee M; Chen H; Li Y; Zhao Y; Liu F; Oi N; Bode AM; Dong Z; Kim DJ
    Cancer Lett; 2019 Apr; 448():20-30. PubMed ID: 30716361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3,3'-Diindolylmethane potentiates paclitaxel-induced antitumor effects on gastric cancer cells through the Akt/FOXM1 signaling cascade.
    Jin H; Park MH; Kim SM
    Oncol Rep; 2015 Apr; 33(4):2031-6. PubMed ID: 25633416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular and Molecular Mechanisms of 3,3'-Diindolylmethane in Gastrointestinal Cancer.
    Kim SM
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27447608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells.
    Bhuiyan MM; Li Y; Banerjee S; Ahmed F; Wang Z; Ali S; Sarkar FH
    Cancer Res; 2006 Oct; 66(20):10064-72. PubMed ID: 17047070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenethyl isothiocyanate inhibited tumor migration and invasion via suppressing multiple signal transduction pathways in human colon cancer HT29 cells.
    Lai KC; Hsu SC; Kuo CL; Ip SW; Yang JS; Hsu YM; Huang HY; Wu SH; Chung JG
    J Agric Food Chem; 2010 Oct; 58(20):11148-55. PubMed ID: 20863062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apigenin inhibits cell proliferation, migration, and invasion by targeting Akt in the A549 human lung cancer cell line.
    Zhou Z; Tang M; Liu Y; Zhang Z; Lu R; Lu J
    Anticancer Drugs; 2017 Apr; 28(4):446-456. PubMed ID: 28125432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer.
    Kong D; Li Y; Wang Z; Banerjee S; Sarkar FH
    Cancer Res; 2007 Apr; 67(7):3310-9. PubMed ID: 17409440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of uPA and its receptor uPAR by 3,3'-diindolylmethane (DIM) leads to the inhibition of prostate cancer cell growth and migration.
    Ahmad A; Kong D; Sarkar SH; Wang Z; Banerjee S; Sarkar FH
    J Cell Biochem; 2009 Jun; 107(3):516-27. PubMed ID: 19330806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3,3'-Diindolylmethane modulates aryl hydrocarbon receptor of esophageal squamous cell carcinoma to reverse epithelial-mesenchymal transition through repressing RhoA/ROCK1-mediated COX2/PGE
    Zhu P; Yu H; Zhou K; Bai Y; Qi R; Zhang S
    J Exp Clin Cancer Res; 2020 Jun; 39(1):113. PubMed ID: 32546278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.